Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.79 |
| ▸ | PRKCA | P17252 | 2/20 | 0.62 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.62 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.62 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.62 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
| ▸ | CNR2 | P34972 | 1/20 | 0.59 |
| ▸ | TERT | O14746 | 3/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | PPARD | Q03181 | 3/20 | 0.58 |
| ▸ | PPARA | Q07869 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80898 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL10338455 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL18133442 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL10338452 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL6514796 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL61998 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3656513 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL6514791 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL4124375 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL28578863 | 1.00 | LMNA (0.79) | LMNAPRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023180560-A1 | COMPOSITION FOR ENHANCING KERATIN FIBERS | WELLA GERMANY GMBH (DE) | 2023-09-28 | — | — | WO | claimed |
| US-20250354765-A1 | SYSTEMS AND METHODS FOR MANAGING THERMAL ENERGY | PHASESTOR LLC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-3948138-B1 | THERMAL MANAGEMENT DEVICES AND METHODS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-4042086-B1 | SYSTEMS AND METHODS FOR MANAGING THERMAL ENERGY | PHASESTOR LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-12372289-B2 | Temperature control cart for a payload | VESTURE LLC (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250207841-A1 | TEMPERATURE CONTROL CART FOR A PAYLOAD | VESTURE LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250207867-A1 | THERMAL ENERGY STORAGE SYSTEMS | PHASESTOR LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250207845-A1 | PRODUCT TRANSPORT CONTAINERS | VESTURE LLC (US) | 2025-06-26 | — | — | US | disclosed |
| US-12320583-B2 | Systems for storing and/or transporting temperature-sensitive payloads | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2025-06-03 | — | — | US | disclosed |
| US-20250172320-A1 | CHARGING SYSTEM AND CHARGING CRADLE FOR FOOD TRANSPORTATION SYSTEMS | VESTURE LLC (US) | 2025-05-29 | — | — | US | disclosed |
| WO-2017040591-A1 | MODULAR AND PORTABLE FIXTURES CONTAINING A PHASE CHANGE MATERIAL | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2017-03-09 | — | — | WO | disclosed |
| US-20150204618-A1 | THERMAL ENERGY STORAGE SYSTEMS | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2015-07-23 | — | — | US | disclosed |
| EP-2885591-A1 | THERMAL ENERGY STORAGE SYSTEMS | Phase Change Energy Solutions, Inc. (US) | 2015-06-24 | — | — | EP | disclosed |
| WO-2014031605-A1 | THERMAL ENERGY STORAGE SYSTEMS | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| US-20050043402-A1 | Methods and formulations for counteracting infection of mucosa or skin | LIPOMEDICA EHF. (IS) | 2005-02-24 | — | — | US | disclosed |
| US-6596763-B1 | Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous | LIPOMEDICA EHF. (IS) | 2003-07-22 | — | — | US | disclosed |
| EP-0941087-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | Thormar, Halldor (IS) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998020872-A1 | TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS | THORMAR HALLDOR (IS) | 1998-05-22 | — | — | WO | disclosed |
| US-5391548-A | Transdermal flux enhancing compositions to treat hypertension, diabetes and angina pectoris | PFIZER INC. (US) | 1995-02-21 | — | — | US | disclosed |
| US-5196410-A | Penetration agents | PFIZER INC. (US) | 1993-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043402-A1 | Methods and formulations for counteracting infection of mucosa or skin | MGLL, GK, UGCG | LMNA 2910/4885PRKCA 2219/4885PRKCE 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.